Autoimmunity in context of exposure to SARS-Cov2 virus
References
- Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4): 386-401. doi:10.1111/imm.13443
- Chang R, Yen-Ting Chen T, Wang SI, Hung YM, Chen HY, Wei CJ. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023;56:101783. doi:10.1016/j.eclinm.2022.101783
- Mouzarou A, Ioannou M, Leonidou E, Chaziri I. Pulmonary Embolism in Post-CoviD-19 Patients, a Literature Review: Red Flag for Increased Awareness?. SN Compr Clin Med. 2022;4(1):190. doi:10.1007/s42399-022-01273-3
- Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020;69(12): 1181-1189. doi:10.1007/s00011-020-01401-6
- Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi:10.1016/S0140-6736(20)30937-5
- Tang KT, Hsu BC, Chen DY. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. Front Immunol. 2021;12:645013. Published 2021 Mar 12. doi:10.3389/fimmu.2021.645013
- Marcos-Jubilar M, Lecumberri R, Páramo JA. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives. J Clin Med. 2023;12(4):1399. Published 2023 Feb 9. doi:10.3390/jcm12041399
- Niculae CM, Hristea A, Moroti R. Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review. Biomedicines. 2023;11(3):929. Published 2023 Mar 16. doi:10.3390/biomedicines11030929
- Knight R, Walker V, Ip S, et al. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation. 2022;146(12):892-906. doi:10.1161/CIRCULATIONAHA.122.060785
- Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29:100639. doi:10.1016/j.eclinm.2020.100639
- Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest. 2021;159(3):1182-1196. doi:10.1016/j.chest.2020.11.005
- Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76(10):970-979. doi:10.1136/thoraxjnl-2020-215383
- Hobohm L, Sagoschen I, Barco S, et al. COVID-19 infection and its impact on case fatality in patients with pulmonary embolism. Eur Respir J. 2023;61(1):2200619. Published 2023 Jan 27. doi:10.1183/13993003.00619-2022
- Engelen MM, Vandenbriele C, Balthazar T, et al. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization. Semin Thromb Hemost. 2021;47(4):362-371. doi:10.1055/s-0041-1727284
- Scudiero F, Silverio A, Di Maio M, et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res. 2021;198:34-39. doi:10.1016/j. thromres.2020.11.017
- Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347-1350. doi:10.1182/blood.2020008086
- Vechi HT, Maia LR, Alves MDM. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Rev Inst Med Trop Sao Paulo. 2020;62:e63. Published 2020 Sep 4. doi:10.1590/S1678-9946202062063
- Tveita A, Hestenes S, Sporastøyl ER, et al. Pulmonary embolism in cases of COVID-19 [published correction appears in Tidsskr Nor Laegeforen. 2020 Dec 07;140(1):]. Lungeembolisme ved covid-19 [published correction appears in Tidsskr Nor Laegeforen. 2020 Dec 07;140(1):]. Tidsskr Nor Laegeforen. 2020;140(8):10.4045/tidsskr.20.0366. Published 2020 May 6. doi:10.4045/tidsskr.20.0366
- Moreira BL, Santana PRP, Zanetti G, Marchiori E. COVID-19 and acute pulmonary embolism: what should be considered to indicate a computed tomography pulmonary angiography scan?. Rev Soc Bras Med Trop. 2020;53:e20200267. doi:10.1590/0037-8682-0267-2020
- Vitali C, Minniti A, Caporali R, Del Papa N. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19. Thromb Res. 2020;192:21-22. doi:10.1016/j. thromres.2020.05.00
- Joseph JW, Roberts JC, Weaver CN, Anderson JS, Wong ML. Patients with Mild COVID-19 Symptoms and Coincident Pulmonary Embolism: A Case Series. Clin Pract Cases Emerg Med. 2020;4(3):295-298. doi:10.5811/cpcem.2020.7.48254
- Elkattawy S, Alyacoub R, Singh KS, Fichadiya H, Kessler W. Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2022;10:23247096211058486. doi:10.1177/23247096211058486
- Lupi-Herrera E, Soto-López ME, Lugo-Dimas AJ, et al. Polymorphisms C677T and A1298C of MTHFR Gene: Homocysteine Levels and Prothrombotic Biomarkers in Coronary and Pulmonary Thromboembolic Disease. Clin Appl Thromb Hemost. 2019;25:1076029618780344. doi:10.1177/1076029618780344
- Ivanova NG. Acute Myocardial Infarction, Subclavian Vein Thrombosis, and Pulmonary Embolism Secondary to COVID-19-A Case Report. Medicina (Kaunas). 2023 Mar 26;59(4):656. doi: 10.3390/medicina59040656. PMID: 37109614; PMCID: PMC10146950.
- Mumoli N, Dentali F, Conte G, et al. Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients. PLoS One. 2022;17(1):e0262522. Published 2022 Jan 12. doi:10.1371/journal.pone.0262522
- Hasegawa T, Yazaki Y. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circ J. 2022;86(4):723. doi:10.1253/circj.CJ-21-0882
- Kang J. Unusual arm vein thrombosis after the Moderna (mRNA-1273) COVID-19 vaccination-a case report. Ann Palliat Med. 2022;11(11):3567-3570. doi:10.21037/apm-22-343
- Gonzalez S, Levine DM. Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID-19 vaccine case report. Clin Case Rep. 2023;11(2):e6012. Published 2023 Feb 27. doi:10.1002/ccr3.6012
- Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARSCoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931. Published 2021 Aug 26. doi:10.1136/bmj.n1931
- Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125:102738. doi:10.1016/j.jaut.2021.102738
- Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386-401. doi:10.1111/imm.13443
- Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125:102738. doi:10.1016/j. jaut.2021.102738
- Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol. 2022;12(4):200-223. Published 2022 Jul 20. doi:10.5662/wjm. v12.i4.200
- Chen K, Gao Y, Li J. New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases. Eur J Med Res. 2023;28(1):232. Published 2023 Jul 13. doi:10.1186/s40001-023-01210-7
- Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sánchez Valadez TI, Jara LJ. Two Cases of Graves’ Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants. Thyroid. 2021;31(9):1436-1439. doi:10.1089/thy.2021.0142
- Takedani K, Notsu M, Ishiai N, Asami Y, Uchida K, Kanasaki K. Graves’ disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature. BMC Endocr Disord. 2023;23(1):132. Published 2023 Jun 15.doi:10.1186/s12902-023-01387-2
- Triantafyllidis KK, Giannos P, Stathi D, Kechagias KS. Graves’ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases. Front Endocrinol (Lausanne). 2022;13:938001. Published 2022 Sep 27. doi:10.3389/fendo.2022.938001
- Zettinig G, Krebs M. Two further cases of Graves’ disease following SARS-Cov-2 vaccination. J Endocrinol Invest. 2022;45(1):227-228. doi:10.1007/s40618-021-01650-0
- Weintraub MA, Ameer B, Sinha Gregory N. Graves Disease Following the SARS-CoV-2 Vaccine: Case Series. J Investig Med High Impact Case Rep. 2021;9:23247096211063356. doi:10.1177/23247096211063356
- Singh G, Howland T. Graves’ Disease Following COVID-19 Vaccination. Cureus. 2022;14(4):e24418. Published 2022 Apr 23. doi:10.7759/cureus.24418
- Sriphrapradang C, Shantavasinkul PC. Graves’ disease following SARS-CoV-2 vaccination. Endocrine. 2021;74(3):473-474. doi:10.1007/s12020-021-02902-y
- Pierman G, Delgrange E, Jonas C. Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?. Eur J Case Rep Intern Med. 2021;8(9):002807. Published 2021 Sep 2. doi:10.12890/2021_002807
- Vojdani A, Vojdani E, Kharrazian D. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Front Immunol. 2021;11:617089. Published 2021 Jan 19. doi:10.3389/fimmu.2020.617089
Language: English
Page range: 71 - 78
Published on: Jun 10, 2024
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
Related subjects:
© 2024 Iris-Andreea Negoescu, Ioana-Mădălina Moșteanu, Anca Simionescu, Oana Parlițeanu, Alina Arlet, Cicerone Iordache, Daniel Voinescu, Alina Croitoru, Beatrice Mahler, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.